semaglutide mash GLP-1 therapies: a new frontier in treatment Semaglutide targets MASH molecular pathways

Interestingly, defects in mitochondrial energy metabolism are also present in the brains of patients with AD, leading to neuronal apoptosis and A deposition, which increases ROS production by interfering with mitochondrial calcium homeostasis and ETC function

Adequate levels of GSH are crucial in maintaining reduction-oxidation (redox) balance within body tissues with the ratio of reduced to oxidized glutathione (GSH/GSSG) being a primary indicator of redox state

And if your insurance doesnt cover Ozempic, the out-of-pocket monthly cost ($349 a month for self-pay patients) may be out of the question

Plus, people tend to be open to trying it